Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
OLMA: Olema Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
OLMA
The Story
OLMA
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-41.7%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
10.88×
Olema Pharmaceuticals, Inc.
OLMA
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Olema Pharmaceuticals, Inc.
OLMA
NASDAQ
·
USD
·
Closed
$11.45
−3.13%
$11.45
−$0.37 (3.13%)
52W Range
22th
pctl
Volume
0.48×
avg
Mkt Cap
1.00B
USD
P/E
-5.7
TTM
Div Yield
–
ann
52W Range
22th
pctl
Volume
0.48×
avg
Market Cap
1.00B
USD
P/E Ratio
-5.7
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings